Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
Website:
http://www.trawspharma.comNext earnings report:
09 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Wed, 03 Jul 2024 19:57:17 GMTDividend
Analysts recommendations
Institutional Ownership
What type of business is Traws Pharma?
Traws Pharma, Inc., a clinical stage biopharmaceutical company, focuses on developing small molecule oral product candidates for respiratory viral diseases and cancer. The company is developing investigational novel therapies for influenza and COVID19 that are designed to address treatment resistance, such as TRX01 (travatrelvir), a Mpro/3CL inhibitor in development for the treatment of COVID19; and TRX100 (viroxavir), an endonuclease inhibitor in development for the treatment of pandemic influenza. It is also developing narazaciclib, a multi-kinase CDK4/6 inhibitor, which is in Phase 1/2 clinical trials in patients with cancer, with or without co-administration of letrozole to define the recommended phase 2 dose for further development in endometrial cancer; and oral rigosertib, which is administered alone or in combination for investigation in various cancers. The company was formerly known as Onconova Therapeutics, Inc. and changed its name to Traws Pharma, Inc. in April 2024. Traws Pharma, Inc. was incorporated in 1998 and is headquartered in Newtown, Pennsylvania.
What sector is Traws Pharma in?
Traws Pharma is in the Healthcare sector
What industry is Traws Pharma in?
Traws Pharma is in the Biotechnology industry
What country is Traws Pharma from?
Traws Pharma is headquartered in United States
What is Traws Pharma website?
https://www.trawspharma.com
Is Traws Pharma in the S&P 500?
No, Traws Pharma is not included in the S&P 500 index
Is Traws Pharma in the NASDAQ 100?
No, Traws Pharma is not included in the NASDAQ 100 index
Is Traws Pharma in the Dow Jones?
No, Traws Pharma is not included in the Dow Jones index
When does Traws Pharma report earnings?
The next expected earnings date for Traws Pharma is 09 August 2024